# Passage BIO, Inc.: Form 8-K, filed May 30, 2025

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: 8-K
- Filed: 2025-05-30
- Accepted by EDGAR: May 30, 2025, 16:25 ET
- Period: 2025-05-28
- Accession: 0001104659-25-054907
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000110465925054907/tm2516589d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000110465925054907/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000110465925054907/tm2516589d1_8k.htm

Filed May 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-054907. Last ingested by Listed: Nov 6, 2026, 11:01 ET. No prices; not investment advice.